Thomas Leischner

1 Patent

• US124101382025

  Process Comprising the Use of New Iridium Catalysts for Enantioselective Hydrogenation of 4-substituted 1,2-dihydroquinolines

  Bayer Aktiengesellschaft

  0 cites